Skip to main content

Maraviroc Dosage

Medically reviewed by Drugs.com. Last updated on Oct 27, 2023.

Applies to the following strengths: 150 mg; 300 mg; 25 mg; 75 mg; 20 mg/mL

Usual Adult Dose for:

Usual Pediatric Dose for:

Additional dosage information:

Usual Adult Dose for HIV Infection

With potent CYP450 3A inhibitors (with or without a potent CYP450 3A inducer): 150 mg orally twice a day

With noninteracting concomitant medications: 300 mg orally twice a day

With potent and moderate CYP450 3A inducers (without a potent CYP450 3A inhibitor): 600 mg orally twice a day

Comments:


Use: In combination with other antiretroviral agents, for the treatment of only C-C chemokine receptor type 5 (CCR5)-tropic HIV-1 infection

Usual Pediatric Dose for HIV Infection

ORAL SOLUTION:
Weight At Least 2 kg:
With potent CYP450 3A inhibitors (with or without a potent CYP450 3A inducer):


With noninteracting concomitant medications:

With potent and moderate CYP450 3A inducers (without a potent CYP450 3A inhibitor): Not recommended (insufficient data available to recommended use).

TABLETS:
2 Years or Older Weighing At Least 10 kg:
With potent CYP450 3A inhibitors (with or without a potent CYP450 3A inducer):

With noninteracting concomitant medications:

With potent and moderate CYP450 3A inducers (without a potent CYP450 3A inhibitor): Not recommended (insufficient data available to recommended use).

Comments:

Use: In combination with other antiretroviral agents, for the treatment of only CCR5-tropic HIV-1 infection

Renal Dose Adjustments

Adult Patients:


Pediatric Patients:

Comments:

Liver Dose Adjustments

Adult Patients:


Pediatric Patients: Data not available

Comments:

Precautions

US BOXED WARNING:


CONTRAINDICATIONS:

This drug is not recommended for use in preterm neonates or pediatric patients weighing less than 2 kg.

Consult WARNINGS section for additional precautions.

Dialysis

ESRD on Regular Hemodialysis:
Adult patients:


Pediatric patients: Contraindicated in patients receiving potent CYP450 3A inhibitors or inducers

Comments:

Other Comments

Administration advice:


Storage requirements:

General:

Monitoring:

Patient advice:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.